About RETApro
A UK supplier of tested Retatrutide for laboratory research
RETApro supplies one compound, Retatrutide (LY3437943), to researchers in the United Kingdom. Every batch carries a Certificate of Analysis you can check against the testing laboratory’s own record. We supply it strictly for laboratory and research use. It is not a medicine, and we do not sell it for human or veterinary use.
Last updated 2026-09-29
Company details
- Trading name
- RETApro
- Country
- United Kingdom
- Website
- retapro.co.uk (formerly retapro.net, which redirects here)
- support@retapro.net
- +44 7414 909121
- Support hours
- Mon–Fri, 9am–5pm GMT
- Supplies
- Retatrutide for laboratory and research use only
How we work
- Independent testing. The current batch is 98.0% pure by HPLC–UV (215 nm), tested by PeptideVerify (certificate PV-8B67BB-HAJY, issued 6 July 2026). Verify it with the lab or download the PDF.
- UK stock, cold chain. Orders ship from the UK by Royal Mail Special Delivery Guaranteed in 2–8°C packaging. See shipping & delivery.
- Research use only. Retatrutide is not licensed by the MHRA or any other regulator. We make no therapeutic claims and give no advice on human use. See is Retatrutide legal in the UK?
- Reviewed reference content. Our research library is written from the peer-reviewed literature; see the editorial team.
Not to be confused with
Several unrelated products and companies use similar names. RETApro, at retapro.co.uk, is not affiliated with any of them.
The “RetaPro” tracker app
A mobile dose-tracking app published by Agora Labs. RETApro has no connection with it and publishes no app.
Sciroxx “RetaPro”
A retatrutide vial sold under the Sciroxx brand. It is not made, tested or sold by RETApro.
RETRAPRO LIMITED
An unrelated UK company registered at Companies House with a similar name. It has nothing to do with this site.
Contact
Email support@retapro.net or message us on WhatsApp (+44 7414 909121), Mon–Fri, 9am–5pm GMT.
Supplied strictly for laboratory and research use only. Not for human or veterinary use. Retatrutide is not approved or licensed as a medicine by the MHRA or any other regulator.
